Zobrazeno 1 - 4
of 4
pro vyhledávání: '"R. M. Franquesa"'
Autor:
A. Arcusa, M. Gallén, M. Nogué, R. M. Franquesa, Luis Cirera, M. Boleda, M.T. Cardona, Serafin Morales, A. Badia, I. Guasch
Publikováno v:
Oncology. 50(4)
Fifty-three patients with advanced non-small cell lung cancer (NSCLC) were trerated with alternating two-drug schedules cisplatin/vindesine and ifosfa-mide/mitomycin. Objective response (complete and partial response) was obtained in 31 % (confidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765726f7eb06d0828c1e9a754c668a22
https://pubmed.ncbi.nlm.nih.gov/8388553
https://pubmed.ncbi.nlm.nih.gov/8388553
Autor:
Luis Cirera, J. Janáriz, E. Saigi, A. Arcusa, K. Villadiego, Miguel Ángel Seguí, R. M. Franquesa, M. Centelles
Publikováno v:
Journal of Clinical Oncology. 23:868-868
868 Background: Combination therapy of Trastuzumab (H) and Vinorelbine (N) has recently been reported to be an active and safe regimen for HER2 positive MBC patients. We report here the preliminary...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddf903ba3cd661d9daff3e5f4c591f0b
https://doi.org/10.1200/jco.2005.23.16_suppl.868
https://doi.org/10.1200/jco.2005.23.16_suppl.868
Autor:
M.P. López, Eduard Batiste-Alentorn, R. M. Franquesa, M. Gallen, I. Moreno, L. Jolis, Rafael Rosell, Albert Abad, A. Arcusa, Albert Font, R. Blanco
Publikováno v:
European Journal of Cancer. 32:S26
From March 89 to March 92, 164 patients (p) with stage II and III colon cancer were included in a adjuvant trial using an orel schedule of UFT (tegafur+uracil) 400 mg/24 h continuous plus Levamisole 150 mg/24 h × 3 days/15 days. The purpose was to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19c9e5b44e0ae54dd7eb5594dbda5b64
https://doi.org/10.1016/0959-8049(96)84887-8
https://doi.org/10.1016/0959-8049(96)84887-8
Autor:
L. Cirera, A Perez, M. Gallen, M. Nogué, M. Boleda, R. M. Franquesa, Serafin Morales, Joan Carles, A. Badia, C. Vadell
Publikováno v:
European Journal of Cancer. 29:S209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8d1405e8e297b5b8b9583abdcd479c1
https://doi.org/10.1016/0959-8049(93)91788-m
https://doi.org/10.1016/0959-8049(93)91788-m